medmix AG (SWX:MEDX)
Switzerland · Delayed Price · Currency is CHF 11.46
+0.08 (0.70%)
At close: Jan 30, 2026
medmix AG Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 468.1 | 483.9 | 486.6 | 477.1 | 457.3 | 351.3 | |
Revenue Growth (YoY) | -2.42% | -0.56% | 1.99% | 4.33% | 30.17% | -16.50% |
Cost of Revenue | 306.5 | 324.2 | 328.9 | 304.3 | 276.1 | 230.2 |
Gross Profit | 161.6 | 159.7 | 157.7 | 172.8 | 181.2 | 121.1 |
Selling, General & Admin | 119.3 | 116.4 | 119 | 103 | 95.6 | 81.3 |
Research & Development | 21.1 | 25.4 | 25.7 | 23.6 | 23 | 20.2 |
Other Operating Expenses | -0.7 | -1.3 | -4.3 | 5.4 | -0.2 | -0.8 |
Operating Expenses | 139.7 | 140.5 | 140.4 | 132 | 118.4 | 100.7 |
Operating Income | 21.9 | 19.2 | 17.3 | 40.8 | 62.8 | 20.4 |
Interest Expense | -11.4 | -12.1 | -10 | -6.5 | -8.1 | -7.7 |
Interest & Investment Income | 1.2 | 1.1 | 1.3 | 0.7 | - | 0.2 |
Earnings From Equity Investments | -5.7 | -5.7 | - | - | - | - |
Currency Exchange Gain (Loss) | -12.6 | -1.4 | -2.5 | -4.5 | -3.3 | 1.2 |
Other Non Operating Income (Expenses) | 7.7 | -0.9 | -1.3 | 0.2 | -0.3 | -0.2 |
EBT Excluding Unusual Items | 1.1 | 0.2 | 4.8 | 30.7 | 51.1 | 13.9 |
Merger & Restructuring Charges | -1.4 | -2.2 | -0.9 | -1.6 | -0.3 | -3.2 |
Gain (Loss) on Sale of Investments | - | - | - | - | 1.3 | - |
Gain (Loss) on Sale of Assets | 0.2 | 0.8 | 2 | -15.4 | 0.1 | 0.2 |
Asset Writedown | -5.3 | -5.2 | -3 | -1.5 | -0.9 | -0.5 |
Pretax Income | -4.5 | -6.4 | 2.9 | 12.2 | 51.3 | 10.4 |
Income Tax Expense | 0.6 | - | 2.2 | 0.6 | 7.3 | 0.8 |
Earnings From Continuing Operations | -5.1 | -6.4 | 0.7 | 11.6 | 44 | 9.6 |
Minority Interest in Earnings | -0.7 | -1 | -0.4 | - | - | - |
Net Income | -5.8 | -7.4 | 0.3 | 11.6 | 44 | 9.6 |
Net Income to Common | -5.8 | -7.4 | 0.3 | 11.6 | 44 | 9.6 |
Net Income Growth | - | - | -97.41% | -73.64% | 358.33% | -61.91% |
Shares Outstanding (Basic) | 41 | 41 | 41 | 41 | 41 | 34 |
Shares Outstanding (Diluted) | 41 | 41 | 41 | 41 | 41 | 34 |
Shares Change (YoY) | 0.47% | 0.50% | 0.25% | -0.15% | 20.14% | - |
EPS (Basic) | -0.14 | -0.18 | 0.01 | 0.28 | 1.07 | 0.28 |
EPS (Diluted) | -0.14 | -0.18 | 0.01 | 0.28 | 1.07 | 0.28 |
EPS Growth | - | - | -97.38% | -73.81% | 281.77% | - |
Free Cash Flow | 51.7 | 48.1 | 9.7 | 11.2 | 57.5 | 8.5 |
Free Cash Flow Per Share | 1.27 | 1.16 | 0.23 | 0.27 | 1.40 | 0.25 |
Dividend Per Share | 0.500 | 0.500 | 0.500 | 0.500 | 0.500 | - |
Gross Margin | 34.52% | 33.00% | 32.41% | 36.22% | 39.62% | 34.47% |
Operating Margin | 4.68% | 3.97% | 3.55% | 8.55% | 13.73% | 5.81% |
Profit Margin | -1.24% | -1.53% | 0.06% | 2.43% | 9.62% | 2.73% |
Free Cash Flow Margin | 11.04% | 9.94% | 1.99% | 2.35% | 12.57% | 2.42% |
EBITDA | 63.8 | 64 | 60.8 | 80.2 | 105 | 55.6 |
EBITDA Margin | 13.63% | 13.23% | 12.50% | 16.81% | 22.96% | 15.83% |
D&A For EBITDA | 41.9 | 44.8 | 43.5 | 39.4 | 42.2 | 35.2 |
EBIT | 21.9 | 19.2 | 17.3 | 40.8 | 62.8 | 20.4 |
EBIT Margin | 4.68% | 3.97% | 3.55% | 8.55% | 13.73% | 5.81% |
Effective Tax Rate | - | - | 75.86% | 4.92% | 14.23% | 7.69% |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.